17 February 2020 - Deborah Wilkes
Premium
Acquisitions lifted sales at Taisho Pharmaceutical’s Self-Medication division by 14.5% to JPY158 billion (USD1.42 billion) in the nine months ended 31 December 2019.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.